AGA announces support for the reintroduced Treat and Reduce Obesity Act

Notes Reviewers’ Notes

The American Gastroenterological Association (AGA) today announced support for the reintroduced Treat and Reduce Obesity Act (TROA), which would expand Medicare coverage to include screening and treatment of obesity from a diverse range of health care providers who specialize in obesity care. The bill also includes coverage of behavioral counseling, prescription drugs for long-term weight management, and other prevention and treatment options.

As gastroenterologists we see the chronic effects of obesity on patients' health in conditions like metabolic dysfunction-associated fatty liver disease, formerly nonalcoholic fatty liver disease, and gastroesophageal reflux disease. Expanding access and improving early intervention and treatment options will help patients overcome these diseases and live healthier lives. Because many private insurance companies model their health benefits to reflect Medicare, the passage of TROA could lead to improved obesity care options for all Americans."

Rotonya Carr, MD, Chair, AGA Government Affairs Committee

We thank Sens. Tom Carper (D-DE) and Bill Cassidy (R-LA), and Reps. Brad Wenstrup (R-OH), Raul Ruiz (D-CA), Mariannette Miller-Meeks (R-IA) and Gwen Moore (D-WI) for their leadership on H.R. 4818/S. 2407, which is an important step to addressing obesity -; a disease that affects 93 million Americans and could have an economic impact of $4.3 trillion annually if current trends continue.


American Gastroenterological Association

Posted in: Medical Condition News | Healthcare News

Tags: Chronic, Drugs, Fatty Liver, Gastroenterology, Gastroesophageal Reflux Disease, Health Care, Liver, Liver Disease, Medicare, Obesity, Research

Comments (0)
Source: Read Full Article